Jef Benbanaste has led the launch and commercialization of multiple analytical SaaS solutions at Medidata and currently leads Intelligent Trials. Jef has over 16 years of experience improving business processes and decision-making through the use of technology and analytics.
Prior to joining Medidata, Jef led projects at the global insurance company AIG which applied predictive modeling and machine learning techniques to improve risk segmentation and shape business unit strategies. Before that, he was in technology consulting at Deloitte. Jef has a MBA from MIT and a BS from the University of Virginia.
As head of strategic initiatives and a member of the executive leadership team at Suvoda, Kelly is responsible for driving strategic growth across the organization. Prior to this, Kelly spent 4 years as VP of Product Management and Marketing at Suvoda, where she led the strategic direction of the product suite and external communications. She has spent her career in professional services and product development teams, working with Top 10 Pharma companies in e-clinical focused organizations including Phase Forward and Oracle, as well as B2C technology companies. Kelly holds a bachelor’s degree in Interdisciplinary Studies in Bioethics focusing on Neuroscience and Philosophy, a certificate in Conceptual Foundations of Medicine, and a minor in Italian Literature and Language from the University of Pittsburgh.
Michael O’Neal, MD, is Chief Medical Officer at Bioclinica. As a key member of the senior executive team, Dr. O’Neal is responsible for overseeing all medical affairs efforts within the organization, providing strategic leadership to clinical teams while collaborating with sponsors in all aspects of medical imaging protocol development. Drawing on extensive clinical experience in internal medicine and diagnostic radiology, he oversees physician training, service quality, and process improvements while advising on medical operations, regulatory compliance, and the investment of new technologies across medical imaging.
During his 17 years with Bioclinica, Dr. O’Neal has developed and championed improved standards that enable research sites to produce comparable study data across the globe and has provided oversight of imaging data for more than 75 regulatory approvals. Throughout his tenure, he has played a central role in protocol review, charter development, a reader on multiple trials, and independent oversight of over 400 clinical trials to date. He is a member of professional organizations including the Radiological Society of North America, the American College of Radiology, the American Medical Association, the Drug Information Association, the American Society for Clinical Oncology, and the American Society of Hematology. In 2019, he was recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry”.
Prior to his role at Bioclinica, Dr. O’Neal served as Chairman for the Department of Radiology at the Hospital Center at Orange and the head of Central Medical Imaging MRI center. Dr. O’Neal holds certification in Diagnostic Radiology from the American College of Radiology, in addition to fellowship training in Body Imaging. He is the author of several papers, a speaker at many industry meetings, and was a contributor to the iRECIST Committee prior to publication.
Kevin has over 24+ years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning Operations, Project Management, Client Partnerships and Business Transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives.
Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
